Journals / Dicle Tıp Dergisi / 2023 / Cilt: 50 Sayı: 2 - Cilt 50, Sayı 2

Factors Affecting Serum Vitamin D Level in Epilepsy

Pages
156–164
Publication Date
2023-06-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The 25(OH)D level was statistically significantly lower in patients with generalized and complex partial epilepsy who were exposed to the sun for less than one hour per week compared to the focal type and those exposed to the sun for more than one hour per week. p<0.05) Conclusion: 25(OH)D levels should be closely monitored in patients with epilepsy who use ASD for a long time it should be aimed to provide effective seizure control and a positive effect on bone metabolism with appropriate replacement therapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Our aim was evaluate the relationship between 25-Hydroxyvitamin D (25(OH)D) and old and new generation anti-seizure drugs (ASDs), seizure type and seizure frequency in epilepsy patients.
📊
Key Findings & Data:Method: A total of 96 individuals aged 18 years and older with epilepsy were included in this study who were followed up in the SBU Adana City Training and Research Hospital Epilepsy outpatient clinic between January 1, 2020 and November 1, 2022 and met the inclusion criteria.
💡
Conclusion & Impact:The 25(OH)D level was statistically significantly lower in patients with generalized and complex partial epilepsy who were exposed to the sun for less than one hour per week compared to the focal type and those exposed to the sun for more than one hour per week. p<0.05) Conclusion: 25(OH)D levels should be closely monitored in patients with epilepsy who use ASD for a long time it should be aimed to provide effective seizure control and a positive effect on bone metabolism with appropriate replacement therapy.
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Epilepsy · seizure · anti-seizure medication

Abstract

Objective: Our aim was evaluate the relationship between 25-Hydroxyvitamin D (25(OH)D) and old and new generation anti-seizure drugs (ASDs), seizure type and seizure frequency in epilepsy patients. Method: A total of 96 individuals aged 18 years and older with epilepsy were included in this study who were followed up in the SBU Adana City Training and Research Hospital Epilepsy outpatient clinic between January 1, 2020 and November 1, 2022 and met the inclusion criteria. Patients were grouped by age, gender, seizure type, frequency, and ASDs usage (according to their relationship with cytochrome P450 enzymes). Complete blood count, kidney functions, serum ASD levels and calcium, magnesium, phosphate and parathormone levels, season when 25(OH)D were measured, and sun exposure time was also obtained from patient file scans. Results: 55.2% of the patients were women and the mean age was 32.56±12.90 (Min:18 Max:71). 25(OH)D level was found to be deficient or insufficient in 95.8% of the patients. The 25(OH)D level was statistically significantly lower in patients with generalized and complex partial epilepsy who were exposed to the sun for less than one hour per week compared to the focal type and those exposed to the sun for more than one hour per week. p<0.05) Conclusion: 25(OH)D levels should be closely monitored in patients with epilepsy who use ASD for a long time it should be aimed to provide effective seizure control and a positive effect on bone metabolism with appropriate replacement therapy.

🔖

Cite This Article

BOZ, P. B. (2023). Factors Affecting Serum Vitamin D Level in Epilepsy. Dicle Tıp Dergisi, Cilt: 50 Sayı: 2 - Cilt 50, Sayı 2, 156–164. https://ajindex.com/articles/939508

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Bertoldo F, Cianferotti L, Di Monaco M, et al.Definition, Assessment, and Management of VitaminD Inadequacy: Suggestions, Recommendations, andWarnings from the Italian Society for Osteoporosis,Mineral Metabolism and Bone Diseases (SIOMMMS). Nutrients. 2022
  2. 14(19): 4148. doi:10.3390/nu14194148 2.Zelzer S, Meinitzer A, Herrmann M, Goessler W,Enko D. A Novel Method for the Determination ofVitamin D Metabolites Assessed at the Blood-Cerebrospinal Fluid Barrier. Biomolecules. 2021
  3. 11(9): 1288. doi:10.3390/biom11091288 3.Tuckey RC, Cheng CYS, Slominski AT. The serumvitamin D metabolome: What we know and what isstill to discover. J Steroid Biochem Mol Biol. 2019
  4. doi:10.1016/j.jsbmb.2018.09.003 4.Vanherwegen AS, Gysemans C, Mathieu C.Regulation of Immune Function by Vitamin D and Its Use in Diseases of Immunity. Endocrinol Metab ClinNorth Am. 2017
  5. 46(4): 1061-94.doi:10.1016/j.ecl.2017.07.010 5. Gil Á, Plaza-Diaz J, Mesa MD. Vitamin D: Classic and Novel Actions. Ann Nutr Metab. 2018
  6. 72(2): 87-95.doi:10.1159/000486536 6.Holló A, Clemens Z, Kamondi A, Lakatos P, Szűcs A. Correction of vitamin D deficiency improves seizurecontrol in epilepsy: a pilot study. Epilepsy Behav.2012
  7. 24(1): 131-3.doi:10.1016/j.yebeh.2012.03.011 7.Teagarden DL, Meador KJ, Loring DW. Lowvitamin D levels are common in patients withepilepsy. Epilepsy research. 2014
  8. 108(8): 1352-6. 8.McNamara NA, Romanowski EMF, Olson DP,Shellhaas RA. Bone Health and EndocrineComorbidities in Pediatric Epilepsy. Semin PediatrNeurol. 2017
  9. 24(4): 301-9.doi:10.1016/j.spen.2017.10.005 9.AK Türkyılmaz, EE Kurt, G Devrimsel. The effect ofserum vitamin D level and bone mineral density onbalance and the risk of falling in postmenopausalwomen. Diclemedj. 2013
  10. 40(3): 391-5.doi:10.5798/diclemedj.0921.2013.03.0295 10.Feng Y, Cheng G, Wang H, Chen B. Theassociations between serum 25-hydroxyvitamin Dlevel and the risk of total fracture and hip fracture.Osteoporos Int. 2017
  11. 28(5): 1641-52.doi:10.1007/s00198-017-3955-x 11.Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition ofepilepsy. Epilepsia. 2014
  12. 55(4): 475-82.doi:10.1111/epi.12550 12.Tabachnick BG, Fidell LS. Experimental DesignsUsing ANOVA. Vol 724. Thomson/Brooks/ColeBelmont, CA
  13. Lips P, Cashman KD, Lamberg-Allardt C, et al.Current vitamin D status in European and MiddleEast countries and strategies to prevent vitamin Ddeficiency: a position statement of the EuropeanCalcified Tissue Society. Eur